Literature DB >> 23820374

Cristalius: a case in designer drugs.

Jared Lenz1, Jaime Brown, Seth Flagg, Robert Oh, Kenneth Batts, Thomas Ditzler, Jeremy Johnson.   

Abstract

INTRODUCTION: Among recreational drug users, there is a new wave of designer drugs being marketed as "bath salts" and "plant food," which mimic the effects of cocaine/amphetamines and ecstasy (MDMA [3,4-methylenedioxy-N-methamphetamine]). Presented is the case of a patient who snorted a bath salt called Cristalius. CASE
PRESENTATION: A 22-year-old male Soldier was seen in an emergency department for syncope, agitation, confusion, and tachycardia. He reported snorting 1 g of Cristalius the night before. Significant labs included a creatine kinase of 668 U/L, serum creatinine of 1.35 mg/dL, and troponin of 0.516 ng/mL. His abnormal labs trended to normal and a computed tomography coronary angiogram was unremarkable. DISCUSSION: The main ingredients postulated in these products are mephedrone and a synthetic cathinone derivatives of the khat plant. The intended effects include euphoria, empathic connection, mood enhancement, increased sensory perception, with decreased inhibition. Unwanted sympathomimetic side effects include hypertension, tachycardia, chest pain, diaphoresis, dilated pupils, seizures, bruxism, and headaches. Neuropsychiatric symptoms include agitation, anxiety, paranoia, tremors, and insomnia.
CONCLUSION: No treatment guidelines currently exist for mephedrone or MDPV (3,4-methylenedioxypyrovalerone) toxicity. If suspected, ensure adequate cardiac evaluation is completed regardless of age. Appropriate supportive care and addressing any complications is the primary treatment. Reprint &
Copyright © 2013 Association of Military Surgeons of the U.S.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23820374     DOI: 10.7205/MILMED-D-12-00393

Source DB:  PubMed          Journal:  Mil Med        ISSN: 0026-4075            Impact factor:   1.437


  3 in total

1.  Pharmacotherapy of Patients Taking New Psychoactive Substances: A Systematic Review and Analysis of Case Reports.

Authors:  Michal Ordak; Aleksandra Zmysłowska; Miłosz Bielski; Daniel Rybak; Maja Tomaszewska; Katarzyna Wyszomierska; Aleksandra Kmiec; Natalia Garlicka; Maria Zalewska; Michal Zalewski; Tadeusz Nasierowski; Elzbieta Muszynska; Magdalena Bujalska-Zadrozny
Journal:  Front Psychiatry       Date:  2021-04-23       Impact factor: 4.157

2.  Influence of Contingent and Noncontingent Drug Histories on the Development of High Levels of MDPV Self-Administration.

Authors:  Michelle R Doyle; Agnieszka Sulima; Kenner C Rice; Gregory T Collins
Journal:  J Pharmacol Exp Ther       Date:  2021-08-19       Impact factor: 4.030

3.  Mephedrone and nicotine: oxidative stress and behavioral interactions in animal models.

Authors:  Barbara Budzynska; Anna Boguszewska-Czubara; Marta Kruk-Slomka; Jacek Kurzepa; Grazyna Biala
Journal:  Neurochem Res       Date:  2015-04-11       Impact factor: 3.996

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.